PBO PH20 SC, ARGX-113
ARGX-113-2010
Phase 3 small_molecule active
Quick answer
PBO PH20 SC, ARGX-113 for Bullous Pemphigoid is a Phase 3 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Bullous Pemphigoid
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active